
Company valuation, historical trends, and peer comparisons.
According to OraSure Technologies, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 117.39M. This represents a change of 87.64% compared to the average of 62.56M of the last 4 quarters.
The mean historical Enterprise Value of OraSure Technologies, Inc. over the last ten years is 416.22M. The current 117.39M Enterprise Value has changed -71.80% with respect to the historical average. Over the past ten years (40 quarters), OSUR's Enterprise Value was at its highest in in the September 2017 quarter at 1.27B. The Enterprise Value was at its lowest in in the December 2025 quarter at -12891280.00.
Average
416.22M
Median
402.63M
Minimum
-8247300.00
Maximum
1.04B
Discovering the peaks and valleys of OraSure Technologies, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 174.98%
Maximum Annual Enterprise Value = 1.04B
Minimum Annual Increase = -153.05%
Minimum Annual Enterprise Value = -8247300.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | -8247300.00 | -153.05% |
| 2024 | 15.55M | -95.21% |
| 2023 | 324.55M | 16.73% |
| 2022 | 278.04M | -46.64% |
| 2021 | 521.03M | -6.94% |
| 2020 | 559.87M | 31.19% |
| 2019 | 426.76M | -31.76% |
| 2018 | 625.35M | -39.92% |
| 2017 | 1.04B | 174.98% |
| 2016 | 378.51M | 40.66% |
The current Enterprise Value of OraSure Technologies, Inc. (OSUR) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
110.62M
5-year avg
226.18M
10-year avg
416.22M
OraSure Technologies, Inc.’s Enterprise Value is greater than Nyxoah S.A. (68.47M), less than Prenetics Global Limited (231.10M), less than Utah Medical Products, Inc. (135.88M), less than Genfit S.A. (584.82M), greater than Perspective Therapeutics, Inc. (82.18M), less than Neuronetics, Inc. (236.48M), less than Protara Therapeutics, Inc. (130.75M), greater than Neonc Technologies Holdings, Inc. (92.55M), less than Nautilus Biotechnolgy, Inc. (327.06M), less than Profound Medical Corp. (223.47M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 68.47M | $89.64M | |
| 231.10M | $289.47M | |
| 135.88M | $220.90M | |
| 584.82M | $445.68M | |
| 82.18M | $126.71M | |
| 236.48M | $169.16M | |
| 130.75M | $145.08M | |
| 92.55M | $94.19M | |
| 327.06M | $310.79M | |
| 223.47M | $255.00M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OraSure Technologies, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OraSure Technologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is OraSure Technologies, Inc.'s Enterprise Value?
What is the highest Enterprise Value for OraSure Technologies, Inc. (OSUR)?
What is the 3-year average Enterprise Value for OraSure Technologies, Inc. (OSUR)?
What is the 5-year average Enterprise Value for OraSure Technologies, Inc. (OSUR)?
How does the current Enterprise Value for OraSure Technologies, Inc. (OSUR) compare to its historical average?